Eurand Reports Recent Developments and Second Quarter 2008 Financial Results
07 août 2008 07h00 HE
|
Eurand N.V.
Highlights:
* Received approvable letter for New Drug Application (NDA) for
EUR-1008 (Zentase(r))
* Achieved successful FDA pre-approval inspection of Milan
manufacturing facility...
Eurand to Receive $35 Million Payment in Litigation Settlement
06 août 2008 08h55 HE
|
Eurand N.V.
DAYTON, Ohio, Aug. 6, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX) today announced that Eurand Inc. and UCB, Inc. have settled long-running litigation concerning a 1999 development, license and...
Eurand Enters Agreement With Daewoong Pharmaceutical Co. Ltd (South Korea) for Once-Daily Extended Release Muscle Relaxant
01 août 2008 09h45 HE
|
Eurand N.V.
PHILADELPHIA, Pa., Aug. 1, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand Announces Conference Call On Second Quarter 2008 Financial Results
18 juil. 2008 08h00 HE
|
Eurand N.V.
AMSTERDAM, The Netherlands, July 18, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand Industrial Award Honors Achievement in Drug Delivery Research
16 juil. 2008 16h11 HE
|
Eurand N.V.
MILAN, Italy, July 16, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX) and the Controlled Release Society (CRS) announced today that the 2008 Eurand Industrial Award has been presented to...
Eurand Names Bill Newbould Vice President, Investor Relations
10 juil. 2008 08h00 HE
|
Eurand N.V.
PHILADELPHIA, July 10, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand Receives Approvable Letter From FDA for EUR-1008 (Zentase)
18 juin 2008 16h05 HE
|
Eurand N.V.
PHILADELPHIA, June 18, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand to Be Issued U.S. Patent for Amrix(r)
03 juin 2008 09h00 HE
|
Eurand N.V.
DAYTON, Ohio, June 3, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
Eurand to Present At UBS Global Specialty and Generic Pharmaceuticals Conference
20 mai 2008 08h00 HE
|
Eurand N.V.
AMSTERDAM, May 20, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical...
Eurand Announces Annual General Meeting of Shareholders Date of May 30, 2008
15 mai 2008 16h00 HE
|
Eurand N.V.
AMSTERDAM, The Netherlands, May 15, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...